Clinical Trials Browser

Interventional × Carcinoma, Hepatocellular × guadecitabine × Clear all

NCT03257761 2025-12-05

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Phase 1 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Cholangiocarcinoma

NCT01752933 2024-08-27

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Completed

52 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular